1-1 of 1
Ron L. Paquette
Close
Sort by
Journal Articles

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

Clinical Trials & Observations
Hagop M. Kantarjian, Francis J. Giles, Peter L. Greenberg, Ron L. Paquette, Eunice S. Wang, Janice L. Gabrilove, Guillermo Garcia-Manero, Kuolung Hu, Janet L. Franklin, Dietmar P. Berger
Journal: Blood
Blood (2010) 116 (17): 3163–3170.
https://doi.org/10.1182/blood-2010-03-274753
Published: 2010